Enhanced expression of erythropoietin in the central nervous system of SOD1(G93A) transgenic mice

Brain Research
Yoon Hee ChungChoong Ik Cha

Abstract

In the present study, we investigated the changes of erythropoietin (Epo) expression in the central nervous system (CNS) of SOD1(G93A) transgenic mice as an in vivo model of amyotrophic lateral sclerosis (ALS). In wild-type SOD1 (wtSOD1) transgenic mice, little immunoreactivity was found in all cortical regions. In the cerebral cortex of symptomatic SOD1(G93A) transgenic mice, there was a significant increase in Epo immunoreactivity. In the hippocampal formation, layer-specific alterations in the staining intensity were observed in the CA1-3 areas and dentate gyrus. Epo immunoreactivity was significantly increased in the midbrain, cerebellar cortex and brainstem of SOD1(G93A) transgenic mice. On the contrary, Epo immunoreactivity was moderately stained in the spinal cord and was not different between wtSOD1 and SOD1(G93A) transgenic mice at the age of 8 weeks, 13 weeks and 18 weeks. In the staining of Epo receptor (EpoR), the changing pattern was similar with that of Epo in the spinal cord and hippocampal formation in wtSOD1 and SOD1(G93A) transgenic mice. Although further studies of functional features of Epo in ALS are needed, the first demonstration of increased immunoreactivity for Epo in the CNS of SOD1(G93A) transgenic mi...Continue Reading

References

May 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·M SakanakaR Sasaki
Mar 24, 1999·The Journal of Physiology·R AssandriA Gorlach
Aug 11, 2000·European Journal of Pharmacology·G CalapaiM Buemi
Aug 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·K L JinD A Greenberg
Sep 2, 2000·Current Opinion in Neurology·A Al-Chalabi, P N Leigh
Sep 14, 2000·Proceedings of the National Academy of Sciences of the United States of America·M L BrinesA Cerami
Oct 6, 2000·The Journal of Clinical Investigation·G L Semenza
Mar 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·A L SirénP Ghezzi
Jun 2, 2001·The New England Journal of Medicine·L P Rowland, N A Shneider
Aug 2, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·W M Campana, R R Myers
Mar 14, 2002·European Journal of Pharmacology·Maria A CataniaGioacchino Calapai
Apr 26, 2002·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Zhao Zhong ChongKenneth Maiese
Jun 6, 2002·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·K S PaulusI Aiello
Jun 18, 2002·Brain Research. Cognitive Brain Research·Hasmet A HanagasiTamer Demiralp
Sep 18, 2003·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·Michael Strong, Jeffrey Rosenfeld

❮ Previous
Next ❯

Citations

Nov 1, 2008·Therapeutic Advances in Neurological Disorders·Claudia BartelsHannelore Ehrenreich
Jun 30, 2016·Expert Opinion on Pharmacotherapy·H BlascoP H Gordon
Jan 18, 2015·Journal of Neurology, Neurosurgery, and Psychiatry·Giuseppe LauriaUNKNOWN EPOS Trial Study Group
Mar 17, 2007·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Giuliano GrignaschiCaterina Bendotti
Feb 17, 2005·Brain Research·Jing ZhangMichael Chopp
Dec 27, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·George A KaysenGlenn M Chertow
Mar 21, 2007·Neuroscience Letters·Johannes BrettschneiderHayrettin Tumani

❮ Previous
Next ❯

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.